Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search a test
Simple search

Simple search

*
(*) mandatory field


 

22 Result(s)

Result(s)sorted by
Speciality(ies)/objective(s)
(19)
(5)
(5)
(2)
(1)
(3)
(1)
Technique(s)
(1)
(1)
(10)
(1)
Purpose(s)
(1)
(22)
(1)
(1)
(14)
Quality management
(8)
(14)
Country(ies)
(1)
(12)
(2)
(5)
(2)
RESET
Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • Accreditation
    • Molecular diagnosis of susceptibility to Behcet's disease (HLA-B gene)
    • Laboratoire Cerba
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of susceptibility to Behcet disease (HLA-B gene)
    • EFS Rhône-Alpes
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Accreditation
    • Molecular diagnosis of HLA-B - susceptibility to Behcet's disease, Stevens-Johnson syndrome and ankylosing spondylitis
    • Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular Diagnosis of Autoinflammatory Disease/Recurrent Fever Syndrome NGS Panel and Del/Dup Analysis (17 genes)
    • The Hospital for Sick Children and University of Toronto
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : NGS sequencing (except WES), Array based techniques
    • More information
    • CANADA
    • Ontario
    • TORONTO
    • Accreditation
    • Diagnosis of susceptibility to Behçet disease (HLA-B gene)
    • Biomnis
    • Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • IVRY SUR SEINE
    • Accreditation
    • HLA-B genotyping
    • EFS Angers
    • Purpose(s) : Post-natal diagnosis, Pharmacogenetics, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • ANGERS
    • Accreditation
    • Molecular diagnosis of susceptibility to Behcet disease (HLA-B gene: PCR-SSO)
    • EFS Rhône Alpes - Grenoble
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • RHONE-ALPES
    • LA TRONCHE
    • Accreditation
    • Molecular diagnosis of predisposition to Behçet disease (HLA-B*51 genotyping)
    • EFS Bretagne
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • FRANCE
    • BRETAGNE
    • RENNES
    • HLA-A and HLA-B genotyping by PCR SSP or PCR SSO
    • Etablissement Français du Sang - Pays de Loire
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • NANTES
    • Molecular diagnosis of suceptibility to Behçet disease (HLA-B gene)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of susceptibility to Behcet's disease (HLA-B gene)
    • Biotecnologie Avanzate Srl
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of susceptibility to Behcet disease (HLA-B gene ; LCT)
    • Établissement Français du Sang Alpes-Méditerranée
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Analysis of susceptibility for Behcet disease (HLA-B gene, 51 allele)
    • Laboratório de Análises Clínicas Dr. Joaquim Chaves
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • CENTRO
    • OEIRAS
    • Molecular diagnosis of Behcet disease (HLA-B gene, 51 allele: Sequencing of the exon 2 and 3)
    • Universidade da Madeira
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • ILHAS
    • FUNCHAL
    • Molecular diagnosis of susceptibility to Behçet disease (HLA-B gene: PCR-SSO)
    • CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Diagnosis of predisposition to Behçet disease (HLA-B*51:01 gene)
    • CHU de Reims - Hôpital Robert Debré
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Immunological diagnosis of Behçet disease
    • Policlinico Umberto I
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Immunology
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Diagnosis of vasculitis on nerve and muscle biospy
    • GHU Paris-Sud - Hôpital de Bicêtre
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Pathology
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • LE KREMLIN-BICÊTRE
    • Molecular diagnosis of Behçet disease
    • IRCCS Arcispedale Santa Maria Nuova
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • REGGIO EMILIA
    • Immunological diagnosis of vasculitides (ANCA, ANA, ACPA, cryoglobulins, lymphocyte phenotyping, BAL)
    • Klinikum Bad Bramstedt GmbH
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Immunology
    • More information
    • GERMANY
    • Schleswig-Holstein
    • BAD BRAMSTEDT
    • Molecular diagnosis and serology of susceptibility to Behcet disease (lymphotoxicity and HLA-B51 genotyping)
    • CHU de Bordeaux-GH Pellegrin
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics, Immunology
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Molecular diagnosis of susceptibility to Behcet's disease (HLA-B gene)
    • Istituto Neurologico Mediterraneo - IRCCS Neuromed
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • MOLISE
    • POZZILLI